{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:22:00Z","timestamp":1786980120195,"version":"build-2736575974"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Data on the comparative usefulness of medications commonly prescribed to individuals with alcohol use disorder (AUD) are scarce. This study compared the association between antidepressants, relapse-preventive AUD medication, both, and neither on the risk of subsequent alcohol-related hospitalization in individuals with severe AUD. This retrospective analysis of Swedish nationwide register data used Cox (primary analysis) and logistic (sensitivity analysis) regression models to assess the associations between medication exposure (antidepressants, AUD medication, both, neither) and risk of subsequent alcohol-related hospitalization. The analysis included data on 14,026 individuals who were admitted to the hospital for severe AUD between 2009 and 2020. Antidepressants were not significantly associated with a lower risk of subsequent alcohol-related hospitalization (hazard ratio [HR]\u2009=\u20090.94, 95% confidence interval [CI]\u2009=\u20090.82\u20131.08), but AUD medication was (HR\u2009=\u20090.61, 95% CI\u2009=\u20090.54\u20130.69), as were antidepressants plus AUD medication (HR\u2009=\u20090.63, 95% CI\u2009=\u20090.45\u20130.87) (reference: exposure to neither). Pairwise comparisons showed that AUD medication was associated with a lower risk of hospitalization than antidepressants (HR\u2009=\u20090.65, 95% CI\u2009=\u20090.54\u20130.78). Antidepressants alone were associated with a higher risk than antidepressants plus AUD medication (HR\u2009=\u20091.50, 95% CI\u2009=\u20091.05\u20132.15). The sensitivity analysis confirmed the association between AUD medication and lower hospitalization risk. Antidepressant monotherapy was not associated with a lower risk of subsequent alcohol-related hospitalization, but relapse-preventive medication for AUD was, both alone and in combination with antidepressants. These findings support the use of relapse-preventive medication to reduce hospitalization risk in individuals with severe AUD and raise questions about the benefit of antidepressant monotherapy for this purpose.<\/jats:p>","DOI":"10.1007\/s00406-025-01988-z","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T03:37:41Z","timestamp":1741750661000},"page":"761-770","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antidepressants, relapse-prevention medications and both combined to reduce alcohol-related hospitalizations in individuals with severe alcohol use disorder"],"prefix":"10.1007","volume":"276","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5962-019X","authenticated-orcid":false,"given":"Patrick","family":"Bach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4355-1967","authenticated-orcid":false,"given":"Johan","family":"Franck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1658-9345","authenticated-orcid":false,"given":"Jonas","family":"H\u00e4llgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4209-5728","authenticated-orcid":false,"given":"H\u00e4rje","family":"Widing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8254-7525","authenticated-orcid":false,"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-4226","authenticated-orcid":false,"given":"Jeanette","family":"Westman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"1988_CR1","first-page":"Cd008581","volume":"4","author":"R Agabio","year":"2018","unstructured":"Agabio R, Trogu E, Pani PP (2018) Antidepressants for the treatment of people with co-occurring depression and alcohol dependence. Cochrane Database Syst Rev 4:Cd008581","journal-title":"Cochrane Database Syst Rev"},{"key":"1988_CR2","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1186\/1471-2458-11-574","volume":"11","author":"K Ahacic","year":"2011","unstructured":"Ahacic K, Damstr\u00f6m-Thakker K, K\u00e5reholt I (2011) Recurring alcohol-related care between 1998 and 2007 among people treated for an alcohol-related disorder in 1997: A register study in Stockholm County. BMC Public Health 11:574","journal-title":"BMC Public Health"},{"key":"1988_CR3","doi-asserted-by":"publisher","first-page":"e243387","DOI":"10.1001\/jamanetworkopen.2024.3387","volume":"7","author":"EY Bernstein","year":"2024","unstructured":"Bernstein EY, Baggett TP, Trivedi S, Herzig SJ, Anderson TS (2024) Outcomes after initiation of medications for alcohol use disorder at hospital discharge. JAMA Netw Open 7:e243387\u2013e243387","journal-title":"JAMA Netw Open"},{"key":"1988_CR4","doi-asserted-by":"crossref","unstructured":"Chan P, Yomen K, Turcios J, Richman M (2015) Prescription for antidepressant in reducing future alcohol-related readmission in patients suffering from depression and alcohol use disorder: A retrospective medical record review. Substance Abuse Treatment, Prevention, and Policy 10:48","DOI":"10.1186\/s13011-015-0045-y"},{"key":"1988_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/alcalc\/agy090","volume":"54","author":"J Chick","year":"2019","unstructured":"Chick J (2019) Unhelpful prescribing in alcohol use disorder: risk and averting risk. Alcohol Alcohol 54:1\u20134","journal-title":"Alcohol Alcohol"},{"key":"1988_CR6","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1111\/add.15502","volume":"116","author":"K Donoghue","year":"2021","unstructured":"Donoghue K (2021) The correlates and extent of prescribing of medications for alcohol relapse prevention in England. Addiction 116:3019\u20133026","journal-title":"Addiction"},{"key":"1988_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jad.2015.06.024","volume":"185","author":"JA Foulds","year":"2015","unstructured":"Foulds JA, Adamson SJ, Boden JM, Williman JA, Mulder RT (2015) Depression in patients with alcohol use disorders: systematic review and meta-analysis of outcomes for independent and substance-induced disorders. J Affect Disord 185:47\u201359","journal-title":"J Affect Disord"},{"key":"1988_CR8","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1093\/alcalc\/agw025","volume":"51","author":"JA Foulds","year":"2016","unstructured":"Foulds JA, Rouch S, Spence J, Mulder RT, Sellman JD (2016) Prescribed psychotropic medication use in patients receiving residential addiction treatment. Alcohol Alcohol 51:622\u2013623","journal-title":"Alcohol Alcohol"},{"key":"1988_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","volume":"72","author":"BF Grant","year":"2015","unstructured":"Grant BF, Goldstein RB, Saha TD, Chou SP, Jung J, Zhang H, Pickering RP, Ruan WJ, Smith SM, Huang B, Hasin DS (2015) Epidemiology of dsm-5 alcohol use disorder: results from the National epidemiologic survey on alcohol and related conditions Iii. JAMA Psychiatry 72:757\u2013766","journal-title":"JAMA Psychiatry"},{"key":"1988_CR10","doi-asserted-by":"publisher","first-page":"e1003822","DOI":"10.1371\/journal.pmed.1003822","volume":"18","author":"S Grant","year":"2021","unstructured":"Grant S, Azhar G, Han E, Booth M, Motala A, Larkin J, Hempel S (2021) Clinical interventions for adults with comorbid alcohol use and depressive disorders: A systematic review and network meta-analysis. PLoS Med 18:e1003822","journal-title":"PLoS Med"},{"key":"1988_CR11","unstructured":"Health NCCM, NIf H, Excellence C, Society BP, Psychiatrists RC (2011) Alcohol use disorders: The nice guideline on the diagnosis, assessment and management of harmful drinking and alcohol dependence"},{"key":"1988_CR12","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1111\/add.15384","volume":"116","author":"M Heikkinen","year":"2021","unstructured":"Heikkinen M, Taipale H, Tanskanen A, Mittendorfer-Rutz E, L\u00e4hteenvuo M, Tiihonen J (2021) Real-world effectiveness of Pharmacological treatments of alcohol use disorders in a Swedish nation-wide cohort of 125 556 patients. Addiction 116:1990\u20131998","journal-title":"Addiction"},{"key":"1988_CR13","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.4088\/JCP.10m06217","volume":"72","author":"N Iovieno","year":"2011","unstructured":"Iovieno N, Tedeschini E, Bentley KH, Evins AE, Papakostas GI (2011) Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: A meta-analysis of placebo-controlled randomized trials. J Clin Psychiatry 72:1144\u20131151","journal-title":"J Clin Psychiatry"},{"key":"1988_CR14","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1159\/000522335","volume":"28","author":"F Kiefer","year":"2022","unstructured":"Kiefer F, Batra A, Petersen KU, Ardern IS, Tananska D, Bischof G, Funke W, Lindenmeyer J, Mueller S, Preuss UW (2022) German guidelines on screening, diagnosis, and treatment of alcohol use disorders: update 2021. Eur Addict Res 28:309\u2013322","journal-title":"Eur Addict Res"},{"key":"1988_CR15","doi-asserted-by":"crossref","unstructured":"Kranzler HR, Van Kirk J (2001) Efficacy of naltrexone and acamprosate for alcoholism treatment: A meta-analysis. Alcoholism: Clinical and Experimental Research 25:1335\u20131341","DOI":"10.1097\/00000374-200109000-00014"},{"key":"1988_CR16","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/cns.13437","volume":"26","author":"J Li","year":"2020","unstructured":"Li J, Wang H, Li M, Shen Q, Li X, Rong X, Peng Y (2020) Efficacy of pharmacotherapeutics for patients comorbid with alcohol use disorders and depressive symptoms-a bayesian network meta-analysis. CNS Neurosci Ther 26:1185\u20131197","journal-title":"CNS Neurosci Ther"},{"key":"1988_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13722-024-00471-9","volume":"19","author":"A M\u00e5nsson","year":"2024","unstructured":"M\u00e5nsson A, Danielsson AK, Sj\u00f6qvist H, Glatz T, Lundin A, Wallhed Finn S (2024) Pharmacotherapy for alcohol use disorder among adults with medical disorders in Sweden. Addict Sci Clin Pract 19:41","journal-title":"Addict Sci Clin Pract"},{"key":"1988_CR18","unstructured":"McManus S, Bebbington PE, Jenkins R, Brugha T (2016) Mental health and wellbeing in england: The adult psychiatric morbidity survey 2014. NHS digital"},{"key":"1988_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1192\/bjp.bp.105.011692","volume":"188","author":"AJ Mitchell","year":"2006","unstructured":"Mitchell AJ (2006) Two-week delay in onset of action of antidepressants: new evidence. Br J Psychiatry 188:105\u2013106","journal-title":"Br J Psychiatry"},{"key":"1988_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.drugalcdep.2016.06.027","volume":"166","author":"KC Morley","year":"2016","unstructured":"Morley KC, Logge W, Pearson S-A, Baillie A, Haber PS (2016) National trends in alcohol pharmacotherapy: findings from an Australian claims database. Drug Alcohol Depend 166:254\u2013257","journal-title":"Drug Alcohol Depend"},{"key":"1988_CR21","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1001\/jama.291.15.1887","volume":"291","author":"EV Nunes","year":"2004","unstructured":"Nunes EV, Levin FR (2004) Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA: J Am Med Association 291:1887\u20131896","journal-title":"JAMA: J Am Med Association"},{"key":"1988_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1176\/appi.ajp.2017.1750101","volume":"175","author":"VI Reus","year":"2018","unstructured":"Reus VI, Fochtmann LJ, Bukstein O, Eyler AE, Hilty DM, Horvitz-Lennon M, Mahoney J, Pasic J, Weaver M, Wills CD (2018) The American psychiatric association practice guideline for the Pharmacological treatment of patients with alcohol use disorder. Am J Psychiatry 175:86\u201390","journal-title":"Am J Psychiatry"},{"key":"1988_CR23","doi-asserted-by":"publisher","first-page":"108174","DOI":"10.1016\/j.drugalcdep.2020.108174","volume":"214","author":"A Rittenberg","year":"2020","unstructured":"Rittenberg A, Hines AL, Alvanzo AA, Chander G (2020) Correlates of alcohol use disorder pharmacotherapy receipt in medically insured patients. Drug Alcohol Depend 214:108174","journal-title":"Drug Alcohol Depend"},{"key":"1988_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.psychres.2019.05.038","volume":"278","author":"W Sliedrecht","year":"2019","unstructured":"Sliedrecht W, de Waart R, Witkiewitz K, Roozen HG (2019) Alcohol use disorder relapse factors: A systematic review. Psychiatry Res 278:97\u2013115","journal-title":"Psychiatry Res"},{"key":"1988_CR25","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/archpsyc.63.11.1217","volume":"63","author":"MJ Taylor","year":"2006","unstructured":"Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z (2006) Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry 63:1217\u20131223","journal-title":"Arch Gen Psychiatry"},{"key":"1988_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2004.09.004","volume":"78","author":"M Torrens","year":"2005","unstructured":"Torrens M, Fonseca F, Mateu G, Farr\u00e9 M (2005) Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis. Drug Alcohol Depend 78:1\u201322","journal-title":"Drug Alcohol Depend"},{"key":"1988_CR27","doi-asserted-by":"publisher","first-page":"108964","DOI":"10.1016\/j.drugalcdep.2021.108964","volume":"227","author":"S Wallhed Finn","year":"2021","unstructured":"Wallhed Finn S, Lundin A, Sj\u00f6qvist H, Danielsson A-K (2021) Pharmacotherapy for alcohol use disorders\u2013 unequal provision across sociodemographic factors and co-morbid conditions. A cohort study of the total population in Sweden. Drug Alcohol Depend 227:108964","journal-title":"Drug Alcohol Depend"},{"key":"1988_CR28","first-page":"1775","volume":"72","author":"SH Williams","year":"2005","unstructured":"Williams SH (2005) Medications for treating alcohol dependence. Am Family Phys 72:1775\u20131780","journal-title":"Am Family Phys"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-01988-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00406-025-01988-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-025-01988-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T19:02:33Z","timestamp":1772478153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00406-025-01988-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1988"],"URL":"https:\/\/doi.org\/10.1007\/s00406-025-01988-z","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments and approved by the Swedish Ethical Review Authority (decision id 2019\u2009\u2212\u200900516).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No informed consent was required since no registered person was contacted, and only anonymized data was used in this register-based study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}